...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Exempt Dist.
Reply New Message
Back To Forum List View
Volume
2
Telepanel
Apr 13, 2021 08:38AM
Re: Volume
3
KayakerBC
Apr 13, 2021 09:31AM
Re: Volume
3
fuzzyjr
Apr 13, 2021 01:37PM
Icon president Exempt Dist.
6
RVXoldtimer
Apr 15, 2021 12:19AM

Another promissory note. Well, as long as they are unsecured I suppose it's all good. 

I believe the previous one was for ~$2 Mil CAN.

 

Koo

 

2 Recommendations
Re: Exempt Dist.
3
narmac
Apr 16, 2021 05:41PM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply